GSK's Jemperli Meets Main Goal in Mid-stage Rectal Cancer Trial

Published Date: 15 Jul 2026

GSK said on Monday its cancer drug Jemperli met the primary goal of a ⁠mid-stage trial, with a clinically significant rate of patients showing no detectable signs of cancer...

Read Full News

Latest News

July 24, 2026 This Week in Cardiology Podcast

The first oral PCSK9 inhibitor, another study finding safe MRI scanning in patients with nonconditional CIEDs, the PFA-SHAM trial, and the curious case of orthopedic injuries in cardiology are the topics John Mandrola, MD, discusses in this week’s podcast.

Abdominal Binders Reduce Colonoscopy Time and Pain

A compression device worn around the abdomen during colonoscopy shortens procedure time and reduces discomfort.

No Catheter After Stone Surgery May Reduce Urinary Symptoms

Catheter placement after ureteroscopic lithotripsy appears to be safe and is linked to a lower incidence of pain and urinary urgency 1 day after surgery.

Acute Ischemic Stroke State of the Art

Neurologist Christoph Diener summarizes what randomized studies in the last 4-5 years have taught us about the management of acute ischemic stroke.

Tests Show Moderate Predictive Value for Milk, Egg Allergy

Skin prick tests and specific IgE levels are moderately useful for predicting oral food challenge outcomes in patients with cow’s milk or hen’s egg allergy.

Should IVF Add-On Treatments Continue? Review Raises Doubts

Review finds limited evidence supporting most IVF add-ons, reinforcing calls for stronger trials and transparent counseling before routine use.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Todays Updates

Palliative Care Remains Uncommon in Young Adults With Cancer

Concurrent palliative care use among young adults with advanced cancer is less than 20%, with substantial variation across cancer types.

Latest News

The first oral PCSK9 inhibitor, another study finding safe MRI scanning in patients with nonconditional CIEDs, the PFA-SHAM trial, and the curious case of orthopedic injuries in cardiology are the topics John Mandrola, MD, discusses in this week’s podcast.

A compression device worn around the abdomen during colonoscopy shortens procedure time and reduces discomfort.

Catheter placement after ureteroscopic lithotripsy appears to be safe and is linked to a lower incidence of pain and urinary urgency 1 day after surgery.
HTTP error: 503

Skin prick tests and specific IgE levels are moderately useful for predicting oral food challenge outcomes in patients with cow’s milk or hen’s egg allergy.
HTTP error: 503

News All Time

Persistent Airflow Limitation Ups Asthma Exacerbation Risk

Patients with asthma who have persistent airflow limitation face a nearly twofold higher risk for severe exacerbations and show distinct patterns of lung function decline.

Deep Dive: Why You No Longer Need to Test for Vitamin D

The Endocrine Society scrapped its vitamin D sufficiency threshold in 2024 and told doctors to stop routine testing. The lab order hasn't caught up to the guidelines.

S1 Episode 3: Diagnosis and Management of Complicated UTIs

Drs Anne Lenore Ackerman and Barbara W. Trautner discuss recent changes to the guidelines for the diagnosis and management of complicated UTIs.
HTTP error: 503

African Ancestry Tied to Increased Asthma Risk in Children

Among Black children, percent African ancestry is associated with an increased risk for asthma and allergen-specific sensitization.

Celldex to Stop Skin Disease Study After Trial Setback

Celldex Therapeutics said on Tuesday it would discontinue the development of its experimental drug for a ⁠skin disease after it failed to meet the main goal and key...

GLP-1 Drugs: Is Ozempic Face Changing Aesthetic Care?

Rapid weight loss with GLP-1 drugs is changing aesthetic practice, as surgeons address facial volume loss, excess skin, and new perioperative considerations.

Gradual Belimumab Dose Spacing Appears Feasible in Lupus

Gradually spacing belimumab doses appears feasible in patients with prolonged remission from systemic lupus erythematosus, without any disease flares over a follow-up period of 21 months.

Europe Wants Drug Security, but It Won’t Come Cheap

A new law and EU-wide vulnerability checks aim to end chronic medicine shortages. But reshoring production could raise prices — and reshape who gets treated.

World Cup Injuries Test Sports Medicine

World Cup injuries can end careers in an instant, forcing physicians to balance elite performance demands with the long road to a safe return.

JAK Inhibitors Linked to Higher Cancer Risk Across IMIDs

JAK inhibitors are associated with a higher risk for malignancy than TNF inhibitors across immune-mediated inflammatory diseases, according to a meta-analysis.

Allergy to NSAIDs Confirmed in Only About 3 in 10 Children

Most children suspected of having an allergy to NSAIDs are not truly allergic to them, and in some, a food allergy triggered by the drug may be the real reason, warranting targeted workup.

Gaza Daily Hunt for Water Lays Bare Worsening Health Crisis

Health authorities warn that Gaza is facing an unprecedented collapse of its water and sanitation systems, with consequences that could last decades.

JAK Inhibitor Timing Affects Zoster Vaccine Response in RA

Immediate initiation of JAK inhibitor therapy after recombinant zoster vaccination is linked to lower early immune responses than delayed initiation in patients with rheumatoid arthritis.
HTTP error: 503

Cyclosporiasis: 3 Things to Know About Diagnosis, Management

Awareness, early recognition, and appropriate testing are key.

Recommended News For You

Specialist Referrals Are Critical for Functional High-Risk Multiple Myeloma

PSMA-PET/CT Detects Metastatic Prostate Cancer Missed by Other Imaging

Using MRD Status to Deescalate Multiple Myeloma Therapy

In Biochemically Recurrent Nonmetastatic Prostate Cancer, Apalutamide Presents Its Argument.

Scientists develop scans that light up aggressive cancer tumors for better treatment

FDA Approves Sickle Cell Gene Therapy for Young Kids

Prostate Cancer Treatment Associated With Long-Term Complications

Recommended Articles For You

Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology 

An Introduction To The CA 15-3 Tumor Marker Test For Cancer Patients 

Clinical Perspectives in Oncology for Better Care 

Strategic Practices in Oncology for Specialists 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mental health risk persists years after cancer diagnosis

2.

Breast cancer prevention: How nurse practitioners and physician assistants can help

3.

For treatment, the majority of cancer patients choose complementary therapies.

4.

Cancer mortality continuing to decline, says report

5.

Doctors say lung cancer is still the deadliest cancer, but hope is growing

1.

Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success

2.

Bone Marrow Microenvironment Biomarkers in Hematologic Health

3.

Unleashing Precision Medicine: CRISPR-Cas9 Gene Editing in Hematopoietic Stem Cells

4.

HKDC1 Protein: An Emerging Therapeutic Target in Colon Cancer

5.

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis 

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot